Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'uPAR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 68 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lutz, V; Reuning, U; Kruger, A; Luther, T; von Steinburg, SP; Graeff, H; Schmitt, M; Wilhelm, OG; Magdolen, V
      High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nudemice

      BIOLOGICAL CHEMISTRY
    2. Engelholm, LH; Behrendt, N
      Differential binding of urokinase and peptide antagonists to the urokinasereceptor: Evidence from characterization of the receptor in four primate species

      BIOLOGICAL CHEMISTRY
    3. Connell, RD; Beebe, JS
      Patent focus on cancer chemotherapeutics. III Angiogenesis agents: October2000-March 2001

      EXPERT OPINION ON THERAPEUTIC PATENTS
    4. Okan, E; Drewett, V; Shaw, PE; Jones, P
      The small-GTPase RalA activates transcription of the urokinase plasminogenactivator receptor (uPAR) gene via an AP1-dependent mechanism

      ONCOGENE
    5. Schwab, W; Gavlik, JM; Beichler, T; Funk, RHW; Albrecht, S; Magdolen, V; Luther, T; Kasper, M; Shakibaei, M
      Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta(1)-integrin

      HISTOCHEMISTRY AND CELL BIOLOGY
    6. Konno, H; Abe, J; Kaneko, T; Baba, M; Shoji, A; Sunayama, K; Kamiya, K; Tanaka, T; Suzuki, S; Nakamura, S; Urano, T
      Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    7. Underwood, PA; Bean, PA; Cubeddu, L
      Human endothelial cells grow poorly on vitronectin: Role of PAI-1

      JOURNAL OF CELLULAR BIOCHEMISTRY
    8. Wurfel, J; Seiter, S; Stassar, M; Claas, A; Klas, R; Rosel, M; Marhaba, R; Savelyeva, L; Schwab, M; Matzku, S; Zoller, M
      Cloning of the human homologue of the metastasis-associated rat C4.4A

      GENE
    9. Yanamandra, N; Konduri, SD; Mohanam, S; Dinh, DH; Olivero, WC; Gujrati, M; Nicolson, GL; Obeyeseke, M; Rao, JS
      Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells

      CLINICAL & EXPERIMENTAL METASTASIS
    10. Romer, J; Pyke, C; Lund, LR; Ralfkiaer, E; Dano, K
      Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    11. Seiter, S; Stassar, M; Rappl, G; Reinhold, U; Tilgen, W; Zoller, M
      Upregulation of C4.4 A expression during progression of melanoma

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    12. Solberg, H; Ploug, M; Hoyer-Hansen, G; Nielsen, BS; Lund, LR
      The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    13. Zhong, M; Webb, DJ; Jo, M; Gonias, SL
      Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells

      JOURNAL OF CELL SCIENCE
    14. Khatib, AM; Nip, J; Fallavollita, L; Lehmann, M; Jensen, G; Brodt, P
      Regulation of urokinase plasminogen activator/plasmin-mediated invasion ofmelanoma cells by the integrin vitronectin receptor alpha(v)beta(3)

      INTERNATIONAL JOURNAL OF CANCER
    15. Lash, GE; Fitzpatrick, TE; Graham, CH
      Effect of hypoxia on cellular adhesion to vitronectin and fibronectin

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    16. Wada, M; Wada, NA; Shirono, H; Taniguchi, K; Tsuchie, H; Koga, J
      Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Zhou, L; Hayashi, Y; Itoh, T; Wang, WP; Rui, JA; Itoh, H
      Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma

      PATHOLOGY INTERNATIONAL
    18. Gong, SJ; Rha, SY; Chung, HC; Yoo, NC; Roh, JK; Yang, WI; Lee, KS; Min, JS; Kim, BS; Chung, HC
      Tissue urokinase-type plasminogen activator receptor levels in breast cancer

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    19. Wittliff, JL; Kunitake, ST; Chu, SS; Travis, JC
      Applications of laser capture microdissection in genomics and proteomics

      JOURNAL OF CLINICAL LIGAND ASSAY
    20. Tecimer, C; Doering, DL; Goldsmith, LJ; Meyer, JS; Abdulhay, G; Wittliff, JL
      Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    21. Okusa, Y; Ichikura, T; Mochizuki, H; Shinomiya, N
      Urokinase type plasminogen activator and its receptor regulates the invasive potential of gastric cancer cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    22. Kin, Y; Chintala, SK; Go, Y; Sawaya, R; Mohanam, S; Kyritsis, AP; Rao, JS
      A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas

      INTERNATIONAL JOURNAL OF ONCOLOGY
    23. Salden, M; Splinter, TAW; Peters, HA; Look, MP; Timmermans, M; van Meerbeeck, JPAM; Foekens, JA
      The urokinase-type plasminogen activator system in resected non-small-celllung cancer

      ANNALS OF ONCOLOGY
    24. Witz, IP
      Differential expression of genes by tumor cells of a low or a high malignancy phenotype: The case of murine and human Ly-6 proteins

      JOURNAL OF CELLULAR BIOCHEMISTRY
    25. Herschman, HR; Ferguson, GD; Feldman, JD; Farias-Eisner, R; Vician, L
      Searching for depolarization-induced genes that modulate synaptic plasticity and neurotrophin-induced genes that mediate neuronal differentiation

      NEUROCHEMICAL RESEARCH
    26. Rha, SY; Yang, WI; Gong, SJ; Kim, JJ; Yoo, NC; Roh, JK; Min, JS; Lee, KS; Kim, BS; Chung, HC
      Correlation of tissue and blood plasminogen activation system in breast cancer

      CANCER LETTERS
    27. Morii, T; Yabe, H; Morioka, H; Yamada, R; Nakagawa, T; Toyama, Y
      Prognostic relevance of urokinase type plasminogen activator, its receptorand inhibitors in chondrosarcoma

      ANTICANCER RESEARCH
    28. Fauser, S; Deininger, MH; Kremsner, PG; Magdolen, V; Luther, T; Meyermann, R; Schluesener, HJ
      Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria

      JOURNAL OF NEUROIMMUNOLOGY
    29. Zeslawska, E; Schweinitz, A; Karcher, A; Sondermann, P; Sperl, S; Sturzebecher, J; Jacob, U
      Crystals of the urokinase type plasminogen activator variant beta c-uPA incomplex with small molecule inhibitors open the way towards structure-based drug design

      JOURNAL OF MOLECULAR BIOLOGY
    30. Sidenius, N; Blasi, F
      Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin

      FEBS LETTERS
    31. Hedberg, KK; Stauff, C; Hoyer-Hansen, G; Ronne, E; Griffith, OH
      High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells

      EXPERIMENTAL CELL RESEARCH
    32. Maity, A; Solomon, D
      Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia

      EXPERIMENTAL CELL RESEARCH
    33. Sidenius, N; Sier, CFM; Ullum, H; Pedersen, BK; Lepri, AC; Blasi, F; Eugen-Olsen, J
      Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection

      BLOOD
    34. Miyake, H; Hara, I; Yamanaka, K; Arakawa, S; Kamidono, S
      Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    35. Mohanam, S; Go, Y; Sawaya, R; Venkaiah, B; Mohan, PM; Kouraklis, GP; Gokaslan, ZL; Lagos, GK; Rao, JS
      Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    36. Adermann, K; Wattler, F; Wattler, S; Heine, G; Meyer, M; Forssmann, WG; Nehls, M
      Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily

      PROTEIN SCIENCE
    37. Hansen, TP; Fenger, C; Kronborg, O
      The expression of p53, Ki-67 and urokinase plasminogen activator receptor in colorectal adenomas with true invasion and pseudoinvasion

      APMIS
    38. Loskutoff, DJ; Curriden, SA; Hu, G; Deng, G
      Regulation of cell adhesion by PAI-1

      APMIS
    39. Look, MP; Foekens, JA
      Clinical relevance of the urokinase plasminogen activator system in breastcancer

      APMIS
    40. Brunner, N; Nielsen, HJ; Hamers, M; Christensen, IJ; Thorlacius-Ussing, O; Stephens, RW
      The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer

      APMIS
    41. Sendo, F; Araki, Y
      Regulation of leukocyte adherence and migration by glycosylphosphatidyl-inositol-anchored proteins

      JOURNAL OF LEUKOCYTE BIOLOGY
    42. Li, YH; Wood, N; Yellowlees, D; Donnelly, PK
      Urokinase receptor expression is upregulated by cell culture sparsity in breast cancer cell line BT-20

      ANTICANCER RESEARCH
    43. Li, YH; Wood, N; Yellowlees, D; Donnelly, PK
      Cell surface expression of urokinase receptor in normal mammary epithelialcells and breast cancer cell lines

      ANTICANCER RESEARCH
    44. Zhang, LP; Takahara, T; Yata, Y; Furui, K; Jin, B; Kawada, N; Watanabe, A
      Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells

      JOURNAL OF HEPATOLOGY
    45. Carroll, VA; Binder, BR
      The role of the plasminogen activation system in cancer

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    46. Ossowski, L; Ghiso, JA; Liu, D; Yu, W; Kovalski, K
      The role of plasminogen activator receptor in cancer invasion and dormancy

      MEDICINA-BUENOS AIRES
    47. Albo, D; Berger, DH; Rothman, VL; Tuszynski, GP
      Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion

      JOURNAL OF SURGICAL RESEARCH
    48. Ghiso, JAA; Kovalski, K; Ossowski, L
      Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

      JOURNAL OF CELL BIOLOGY
    49. Yebra, M; Goretzki, L; Pfeifer, M; Mueller, BM
      Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction

      EXPERIMENTAL CELL RESEARCH
    50. Ghiso, JAA; Alonso, DF; Farias, EF; Gomez, DE; Joffe, EBD
      Deregulation of the signaling pathways controlling urokinase production - Its relationship with the invasive phenotype

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    51. Holst-Hansen, C; Hamers, MJAG; Johannessen, BE; Brunner, N; Stephens, RW
      Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies

      BRITISH JOURNAL OF CANCER
    52. CAVALLARO U; WU ZH; DIPALO A; MONTESANO R; PEPPER MS; MAIER JAM; SORIA MR
      FGF-2 STIMULATES MIGRATION OF KAPOSIS SARCOMA-LIKE VASCULAR CELLS BY HGF-DEPENDENT RELOCALIZATION OF THE UROKINASE RECEPTOR

      The FASEB journal
    53. CHUNG HC; RHA SY; PARK JO; YOO NC; KIM JH; ROH JK; MIN JS; LEE KS; KIM BS; KIM JJ
      PHYSIOLOGICAL AND PATHOLOGICAL-CHANGES OF PLASMA UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPEPLASMINOGEN-ACTIVATOR RECEPTOR LEVELS IN HEALTHY FEMALES AND BREAST-CANCER PATIENTS

      Breast cancer research and treatment
    54. ALBO D; BERGER DH; TUSZYNSKI GP
      THE EFFECT OF THROMBOSPONDIN-1 AND TGF-BETA-1 ON PANCREATIC-CANCER CELL INVASION

      The Journal of surgical research (Print)
    55. ZANETTI A; STOPPACCIARO A; MARZULLO A; CIABATTA M; FAZIOLI F; PRAT M; COMOGLIO PM; BARONI CD; RUCO LP
      EXPRESSION OF MET PROTEIN AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR (UPA-R) IN PAPILLARY CARCINOMA OF THE THYROID

      Journal of pathology
    56. PAYSANT J; VASSE M; SORIA J; LENORMAND B; POURTAU J; VANNIER JP; SORIA C
      REGULATION OF THE UPAR UPA SYSTEM EXPRESSED ON MONOCYTES BY THE DEACTIVATING CYTOKINES, IL-4, IL-10 AND IL-13 - CONSEQUENCES ON CELL-ADHESION TO VITRONECTIN AND FIBRINOGEN/

      British Journal of Haematology
    57. LEVENSON AS; KWAAN HC; SVOBODA KM; WEISS IM; SAKURAI S; JORDAN VC
      ESTRADIOL REGULATION OF THE COMPONENTS OF THE PLASMINOGEN-PLASMIN SYSTEM IN MDA-MB-231 HUMAN BREAST-CANCER CELLS STABLY EXPRESSING THE ESTROGEN-RECEPTOR

      British Journal of Cancer
    58. PLESNER T; BEHRENDT N; PLOUG M
      STRUCTURE, FUNCTION AND EXPRESSION ON BLOOD AND BONE-MARROW CELLS OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR, UPAR

      Stem cells
    59. PAPPOT H; HOYERHANSEN G; RONNE E; HANSEN HH; BRUNNER N; DANO K; GRONDAHLHANSEN J
      ELEVATED PLASMA-LEVELS OF UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR INNONSMALL CELL LUNG-CANCER PATIENTS

      European journal of cancer
    60. GO Y; CHINTALA SK; MOHANAM S; GOKASLAN Z; VENKAIAH B; BJERKVIG R; OKA K; NICOLSON GL; SAWAYA R; RAO JS
      INHIBITION OF IN-VIVO TUMORIGENICITY AND INVASIVENESS OF A HUMAN GLIOBLASTOMA CELL-LINE TRANSFECTED WITH ANTISENSE UPAR VECTORS

      Clinical & experimental metastasis
    61. PAPPOT H; SKOV BG; PYKE C; GRONDAHLHANSEN J
      LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN NONSMALL CELL LUNG-CANCER AS MEASURED BY QUANTITATIVE ELISA AND SEMIQUANTITATIVE IMMUNOHISTOCHEMISTRY

      Lung cancer
    62. GORETZKI L; MUELLER BM
      RECEPTOR-MEDIATED ENDOCYTOSIS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATORIS REGULATED BY CAMP-DEPENDENT PROTEIN-KINASE

      Journal of Cell Science
    63. CANTERO D; FRIESS H; DEFLORIN J; ZIMMERMANN A; BRUNDLER MA; RIESLE E; KORC M; BUCHLER MW
      ENHANCED EXPRESSION OF UROKINASE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR IN PANCREATIC-CARCINOMA

      British Journal of Cancer
    64. ITO Y; KOBAYASHI T; TAKEDA T; WAKASUGI E; TAMAKI Y; NAKANO Y; MATSUURA N; MONDEN M
      IMMUNOLOCALIZATION OF THE COMPONENTS OF THE PLASMINOGEN ACTIVATING SYSTEM IN BREAST-CARCINOMA TISSUE

      Oncology Reports
    65. RESNATI M; GUTTINGER M; VALCAMONICA S; SIDENIUS N; BLASI F; FAZIOLI F
      PROTEOLYTIC CLEAVAGE OF THE UROKINASE RECEPTOR SUBSTITUTES FOR THE AGONIST-INDUCED CHEMOTACTIC EFFECT

      EMBO journal
    66. WEBB G; BAKER MS; NICHOLL J; WANG Y; WOODROW G; KRUITHOF E; DOE WF
      CHROMOSOMAL LOCALIZATION OF THE HUMAN UROKINASE PLASMINOGEN-ACTIVATORRECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 GENES - IMPLICATIONS IN COLORECTAL-CANCER

      Journal of gastroenterology and hepatology
    67. WILHELM S; WILHELM O; SCHMITT M; GRAEFF H
      INACTIVATION OF RECEPTOR-BOUND PRO-UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PRO-UPA) BY THROMBIN AND THROMBIN THROMBOMODULIN COMPLEX/

      Biological chemistry Hoppe-Seyler
    68. PLOUG M; ELLIS V
      STRUCTURE-FUNCTION-RELATIONSHIPS IN THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - COMPARISON TO OTHER MEMBERS OF THE LY-6 FAMILY AND SNAKE-VENOM ALPHA-NEUROTOXINS

      FEBS letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 17:42:36